A Randomized, Open Label Multi-Center Study of Single Ag

Project: Research project

Project Details

Description

A Randomized, Open Label Multi-Center Study of Single Agent Larotaxel (XRP9881) Compared to Continuous Administration of 5-FU for the Treatment of Patients with Advanced Pancreatic Cancer Previously Treated with a Gemcitabine-Containing Regimen
StatusFinished
Effective start/end date10/31/0812/31/10

Funding

  • SANOFI-AVENTIS US